Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ritalin XL 60mg capsules
0404000M0BBAFBA
|
Ritalin | Methylphenidate hydrochloride | Central Nervous System | 1 |
|
Ritalin-SR 20mg tablets
0404000M0BBABAH
|
Ritalin | Methylphenidate hydrochloride | Central Nervous System | 1 |
|
Rivastigmine 2mg/ml oral solution
0411000E0AAAHAH
|
Rivastigmine | Rivastigmine | Central Nervous System | 1 |
|
Rivotril 2mg tablets
0408010F0BBABAC
|
Rivotril (Systemic) | Clonazepam | Central Nervous System | 1 |
|
Ropilynz XL 4mg tablets
0409010H0BJABAL
|
Ropilynz XL | Ropinirole hydrochloride | Central Nervous System | 1 |
|
Sertraline 25mg/5ml oral solution
0403030Q0AAAWAW
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 1 |
|
Sibelium 5mg tablets
0406000E0BBACAD
|
Sibelium | Flunarizine dihydrochloride | Central Nervous System | 1 |
|
Sodium Amytal 200mg capsules
0401030E0BBABAB
|
Sodium amytal | Amobarbital sodium | Central Nervous System | 1 |
|
Sofonac 5mg/2.5mg modified-release tablets
0407020AFBEADAC
|
Sofonac | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1 |
|
Stemetil 25mg tablets
0406000T0BBABAH
|
Stemetil (Suppositories/Tablet) | Prochlorperazine maleate | Central Nervous System | 1 |
|
Tadomon 200mg prolonged-release tablets
0407020AGBDADAF
|
Tadomon | Tapentadol | Central Nervous System | 1 |
|
Tadomon 25mg prolonged-release tablets
0407020AGBDAFAI
|
Tadomon | Tapentadol | Central Nervous System | 1 |
|
Taloxa 600mg tablets
0408010AABCAAAB
|
Taloxa | Felbamate | Central Nervous System | 1 |
|
Taloxa 600mg/5ml oral suspension
0408010AABCABAC
|
Taloxa | Felbamate | Central Nervous System | 1 |
|
Tapentadol 250mg modified-release capsules
0407020AGAAANAN
|
Tapentadol | Tapentadol | Central Nervous System | 1 |
|
Tegretol 100mg Chewtabs
0408010C0BBAGAJ
|
Tegretol | Carbamazepine | Central Nervous System | 1 |
|
Tegretol 100mg/5ml liquid (Imported)
0408010C0BBAKAP
|
Tegretol | Carbamazepine | Central Nervous System | 1 |
|
Thioridazine 100mg tablets
0402010W0AAAHAH
|
Thioridazine | Thioridazine | Central Nervous System | 1 |
|
Tramadol 75mg modified-release tablets
040702040AAAPAP
|
Tramadol hydrochloride | Tramadol hydrochloride | Central Nervous System | 1 |
|
Ultramol Soluble tablets
0407010X0BZAAAY
|
Ultramol | Paracetamol combined preparations | Central Nervous System | 1 |
|
Valoid 50mg tablets
0406000F0BBAAAC
|
Valoid (Oral) | Cyclizine hydrochloride | Central Nervous System | 1 |
|
Xeomin 50unit powder for solution for injection vials
0409030B0BEABAD
|
Xeomin | Botulinum toxin type A | Central Nervous System | 1 |
|
Zalasta 10mg tablets
040201060BCADAC
|
Zalasta | Olanzapine | Central Nervous System | 1 |
|
Zelapar 1.25mg oral lyophilisates
0409010T0BFAAAK
|
Zelapar | Selegiline hydrochloride | Central Nervous System | 1 |
|
Zeldox 40mg capsules
0402010AGBBAAAA
|
Zeldox | Ziprasidone hydrochloride | Central Nervous System | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.